Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)

Market Cap	10.87B -3.4%
Revenue (ttm)	2.75B -3.6%
Net Income	166.07M +82.9%
EPS	0.20 +82.8%
Shares Out	824.60M
PE Ratio	65.47
Forward PE	34.34
Dividend	0.06 (0.46%)
Ex-Dividend Date	n/a

Volume	7,299,260
Average Volume	9,848,388
Open	13.44
Previous Close	13.18
Day's Range	12.92 - 13.44
52-Week Range	12.05 - 18.68
Beta	0.08
RSI	43.36
Earnings Date	Mar 26, 2026

About SHE:002675

Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical APIs, finished dosage forms, nuclide drugs, and healthy products for cardiovascular, antitumor, urology, orthopedics, and other therapeutic areas. It offers heparin, chondroitin sulphate sodium and calcium, and glucosamine series products, as well as collagen, hyaluronic acid, and cytochrome C. The company also provides nadroparin calcium, hydrocortisone sodium succinate, chorionic gonadotrophin, and menotropins for...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 2,469
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002675

Financial Performance

In 2024, SHE:002675's revenue was 2.87 billion, a decrease of -12.42% compared to the previous year's 3.28 billion. Earnings were 183.83 million, a decrease of -12.35%.